{"id":"W4405545882","doi":"10.1186/s42358-024-00402-x","title":"Integrated safety analysis of tofacitinib from Phase 2 and 3 trials of patients with ankylosing spondylitis","year":2024,"lang":"en","type":"article","venue":"Advances in Rheumatology","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"Pfizer (Canada)","funders":"Pfizer","keywords":"Tofacitinib; Medicine; Ankylosing spondylitis; Internal medicine; Adverse effect; Placebo; Rheumatoid arthritis; Janus kinase inhibitor; Randomized controlled trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001763362,0.0001339257,0.001370652,0.0003656073,0.00001950306,0.000003773103,0.00003158147,0.00005830747,0.0007821252],"category_scores_gemma":[0.0002637751,0.00009301949,0.0001007503,0.0007114675,0.0002074129,0.0001048952,0.00002265333,0.00007670005,5.100797e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002999729,"about_ca_system_score_gemma":0.00003589035,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004280403,"about_ca_topic_score_gemma":0.0003987413,"domain_scores_codex":[0.9986358,0.00009926676,0.0007367467,0.0002649078,0.0001189469,0.0001443385],"domain_scores_gemma":[0.9988579,0.000702814,0.0001784952,0.0001424852,0.00008036453,0.00003790475],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003161501,0.0003444868,0.9074104,0.0001735403,0.00216453,0.00007505613,0.0006257173,0.000007505848,0.00003730525,0.0009258779,0.000006982639,0.08506707],"study_design_scores_gemma":[0.08313385,0.005496585,0.7178239,0.008583563,0.01162315,0.00008728047,0.003984682,0.002175605,0.003793357,0.002241435,0.1602392,0.0008173873],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9546178,0.02875333,0.0002685683,0.00004033423,0.0001163942,0.0002321139,0.01581408,0.00001591203,0.0001414789],"genre_scores_gemma":[0.9882941,0.006562662,0.001131987,0.00000788542,0.000002140552,0.00001348394,0.003971915,0.0000093868,0.000006432252],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1895866,"threshold_uncertainty_score":0.8563723,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01489621451102865,"score_gpt":0.3301643968544449,"score_spread":0.3152681823434163,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}